Cell-based aptamer selection for diagnosing cancer and predicting cancer progression
- 1 August 2009
- journal article
- Published by Springer Nature in Toxicology and Environmental Health Sciences
- Vol. 1 (2) , 140-143
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Aptamer Directly Evolved from Live Cells Recognizes Membrane Bound Immunoglobin Heavy Mu Chain in Burkitt's Lymphoma CellsMolecular & Cellular Proteomics, 2007
- Selection of Aptamers for Molecular Recognition and Characterization of Cancer CellsAnalytical Chemistry, 2007
- Optimization and Modifications of Aptamers Selected from Live Cancer Cell LinesChemBioChem, 2007
- Aptamers evolved from live cells as effective molecular probes for cancer studyProceedings of the National Academy of Sciences, 2006
- Endemic Burkitt's lymphoma: a polymicrobial disease?Nature Reviews Microbiology, 2005
- ADAMs: key components in EGFR signalling and developmentNature Reviews Molecular Cell Biology, 2005
- Pathology of the Future: Molecular Profiling for Targeted TherapyCancer Investigation, 2005
- Natural and engineered nucleic acids as tools to explore biologyNature, 2004
- A tenascin-C aptamer identified by tumor cell SELEX: Systematic evolution of ligands by exponential enrichmentProceedings of the National Academy of Sciences, 2003
- Looking Beyond Morphology: Cancer Gene Expression Profiling Using DNA MicroarraysCancer Investigation, 2003